在基于腺病毒的癌症免疫疗法期间,对乙化的多层控制
Akhila Parthasarathy1, Maria Frost2, Andrew G Gillard1
1Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Molecular therapy. Oncology
|April 16, 2025
概括
瘤性腺病毒通过操纵宿主细胞乙化,在癌症病毒疗法中表现有前途. 将这些病毒与乙化修饰剂结合起来,可能会提高癌症治疗结果.
科学领域:
- 病毒学 病毒学
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- 腺病毒是强大的基因传递载体和瘤病毒,在癌症病毒疗法试验中普遍存在.
- 具有复制能力的腺病毒因其高效的细胞吸收而为各种瘤提供治疗潜力.
- 腺病毒对宿主细胞乙瘤调节的操纵越来越多地被认为是癌症治疗中的作用.
研究的目的:
- 审查影响宿主基因组乙组的病毒过程.
- 讨论差异性乙化如何影响宿主抗病毒防御.
- 探索将乙化修饰剂与瘤性腺病毒结合起来,以改善病毒免疫治疗结果.
主要方法:
- 对腺病毒和宿主细胞乙化研究的文献综述.
- 对影响宿主基因组乙化的病毒机制的分析.
- 检查乙化和抗病毒免疫之间的相互作用.
主要成果:
- 腺病毒在复制过程中积极重定向或抑制宿主细胞乙化.
- 改变的乙化模式会影响抗病毒免疫反应的有效性.
- 这项研究强调了在癌症病毒治疗中向乙基的潜力.
结论:
- 腺病毒对宿主乙化的影响为表观遗传驱动的癌症提供了治疗机会.
- 与型腺病毒一起调节乙化可能会提高病毒免疫治疗的疗效.
- 对乙化修饰剂和型腺病毒进行进一步的研究是有必要的,以改善癌症治疗.
更多相关视频
13:36Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
10.3K
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
7.6K
相关概念视频
01:27Tumor Immunotherapy
404
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
404
02:04Covalently Linked Protein Regulators
6.7K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.7K